Eva Versteijne

3PUBLICATIONS
14CO-AUTHORS
Jewish studiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 23, 2022
Reply to W. Attaallah, A. Jain et al, and P. Mroczkowski et al.

Eva Versteijne, Jacob L van Dam, Marc G Besselink

|Jan 27, 2022
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

Eva Versteijne, Jacob L van Dam, Mustafa Suker

Pageof 1